News Search Results
Jul 08, 2026, 10:00 ET Cardiovascular Clinical Sciences (CCS) congratulates Marvin A. Konstam, MD, on being named a recipient of the 2026 Heart Failure Collaboratory (HFC) Lifetime Achievement Award
a leading cardiovascular and renal clinical research organization providing scientific leadership and operational expertise for pharmaceutical, biotechnology, and medical device development programs worldwide. CCS partners with sponsors to advance innovative therapies through high-quality clinical trial
More news about: Cardiovascular Clinical Sciences
Jul 08, 2026, 09:00 ET The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy
Inc. (OTCQB: AVAI) is an emerging biotechnology company developing cell-based therapies for diabetes, age-related disorders and anti-aging [1]. Its strategic anchor is Klothonova, its joint venture with Austrianova, a Singapore-based biotechnology company specializing in cell encapsulation,
More news about: USA News Group
Jul 08, 2026, 08:00 ET Spectrum Science Appoints Industry Veteran Marie Emms as President of Clinical Business
years of healthcare communications experience, including 26 years focused exclusively on clinical trials. She has supported pharmaceutical and biotechnology companies across a wide range of therapeutic areas and every stage of the trial journey, from awareness and informed consent to compliance and adherence."Marie's
More news about: Spectrum Science
Jul 08, 2026, 08:00 ET Paine Schwartz Partners Completes Structured Minority Investment in AMFRESH Group and its Subsidiary BLOOM FRESH
innovation, science, and technology. Through its vertically integrated business model, the Group combines proprietary genetics and breeding, agriscience, biotechnology, sustainable farming, and global commercialization to translate scientific innovation into commercial impact at scale. With more than 95 years of
More news about: Paine Schwartz Partners
Jul 08, 2026, 08:00 ET Mighty Therapeutics Announces First Patient Dosed in Phase 4 Confirmatory Study of Elamipretide in Barth Syndrome
Mighty Therapeutics (the "Company" or "Mighty"), a commercial-stage biotechnology company pioneering a new class of medicines that directly target mitochondrial dysfunction in rare and age-related diseases, today announced that
More news about: Mighty Therapeutics
Jul 08, 2026, 07:00 ET RoosterBio and Applied StemCell Partner to Advance Scalable iPSC-Based Bioprocess Solutions
MILPITAS, Calif. and FREDERICK, Md., July 8, 2026 /PRNewswire/ -- Applied StemCell, Inc. ("ASC"), a biotechnology company with deep expertise and intellectual property in induced pluripotent stem cell (iPSC) technology, and RoosterBio, Inc., a leading supplier
More news about: RoosterBio, Inc.
Jul 08, 2026, 06:30 ET Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio
company generated over $1.2 billion in net sales. Its more than 500,000 products are used globally by academic researchers, biopharmaceutical and biotechnology companies, and clinical diagnostic laboratories.For more information on Bio-Techne and its brands, please visit
More news about: Bio-Techne Corporation
Jul 08, 2026, 05:42 ET Yatsen Group Announces Partnership with Sephora China, Cementing Position as a Science-Led Beauty Innovation Leader
innovation by Yatsen Group is epitomized by the core product lineups driving Perfect Diary's entry into Sephora. As breakthrough products blending biotechnology with beauty, the Perfect Diary Biolip Essence Lipstick 3.0 and Biolip Essence Matte Lipstick 3.0 utilize exclusive patented technology to mimic
More news about: Yatsen Holding Limited
Jul 08, 2026, 03:00 ET Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia
https://doi.org/10.1016/j.jhep.2026.05.011About GenespireGenespire is a biotechnology company developing off-the-shelf immune shielded lentiviral vector-based gene therapies for pediatric patients affected by genetic diseases. ISLVs
More news about: Genespire
Jul 07, 2026, 19:00 ET OTR Therapeutics Enters Strategic Collaboration with LG Chem to Accelerate Development of Novel Oncology Therapies
SHANGHAI, July 7, 2026 /PRNewswire/ -- OTR Therapeutics, a clinical-stage biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, today announced that it has entered into a strategic
More news about: OTR Therapeutics
Jul 07, 2026, 13:45 ET Las Vegas Global Economic Alliance Showcases Southern Nevada's Growing Bioscience Ecosystem at BIO International Convention 2026
Development (GOED) and the city of Las Vegas to showcase the region's strengths in biotechnology, healthcare innovation, research and commercialization.The BIO International Convention, the world's largest biotechnology conference, welcomed more than 20,000 attendees and facilitated more than 66,000
More news about: The Las Vegas Global Economic Alliance
Jul 07, 2026, 12:31 ET In Vitro Fertilization Market Outlook 2026-2031: Rising Infertility Rates & Advancements in Assisted Reproductive Technologies Drive Global Market Growth, Says Mordor Intelligence
population. The market is benefiting from continuous research in reproductive medicine and increasing collaboration between fertility centers, biotechnology companies, and medical device manufacturers. As assisted reproductive technologies continue to evolve, healthcare providers are increasingly adopting
More news about: Mordor Intelligence Private Limited
Jul 07, 2026, 12:30 ET EDETEK to Support the FDA's Real-Time Clinical Trials Initiative with Its R&D Cloud and Sponsor Partnership Program
regulatory readiness.EDETEK's R&D Cloud and its RTCT sponsor partnership program are available immediately to global clinical trial sponsors, biotechnology companies, and CRO partners pursuing early-phase, AI-enabled clinical development.About EDETEKEDETEK is a leading provider
More news about: EDETEK, Inc.
Jul 07, 2026, 10:46 ET Global Biopharmaceutical Processing Equipment & Consumables Market is Anticipated to Cross the USD 110 Billion Mark by 2034 | DelveInsight
number of biopharmaceutical and biotechnology companies, which represent the primary consumers of bioprocessing equipment and consumables for both clinical development and commercial manufacturing.Furthermore, favorable government initiatives promoting biotechnology and biomanufacturing, coupled
More news about: DelveInsight Business Research, LLP
Jul 07, 2026, 10:15 ET Medical Equipment Cooling Market worth $0.84 billion by 2031 | MarketsandMarkets™
the forecast period. This is mainly attributed to the rapid expansion of healthcare infrastructure, increasing investments in pharmaceutical and biotechnology manufacturing, and growing adoption of advanced diagnostic and laboratory equipment. Rising healthcare expenditure, improving access to medical
More news about: MarketsandMarkets
Jul 07, 2026, 10:01 ET Gene Editing Market to Reach US$30.5 Billion by 2033 as Precision Medicine and CRISPR Innovation Accelerate Growth - Persistence Market Research
the market with a 52% revenue share, supported by its advanced biotechnology ecosystem and strong clinical research activity.Asia Pacific is anticipated to be the fastest-growing regional market, driven by expanding biotechnology infrastructure, government investments, and precision medicine
More news about: Persistence Market Research Pvt. Ltd.
Jul 07, 2026, 09:43 ET Insilico Initiates Phase III Clinical Trial for Rentosertib, Its AI-Empowered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis
inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-to-clinic journey in Nature Biotechnology, and positive Phase IIa clinical results in Nature MedicineRentosertib represents a novel mechanism, novel AI-identified target, and novel
More news about: Insilico Medicine
Jul 07, 2026, 09:00 ET Neurophet Showcases 'Neurophet AQUA AD Plus' at AAIC 2026, Expands Global Partnerships
quantitative PET image analysis.Through its participation in AAIC 2026, Neurophet will engage in partnering meetings with global pharmaceutical and biotechnology companies, as well as potential customers, to explore business development collaborations in the field of imaging biomarker analysis. In particular,
More news about: Neurophet
Jul 07, 2026, 09:00 ET Catalent and Nanoscope Therapeutics Expand Partnership to Support Late-Phase Development and Commercial Supply of Lead Optogenetic Gene therapy, MCO-010
Nanoscope Therapeutics, a biotechnology company committed to commercializing novel, disease-agnostic, vision-restoring therapies for patients with photoreceptor loss due to retinal degenerations,
More news about: Nanoscope Therapeutics
Jul 07, 2026, 08:50 ET Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
continued to strengthen its position as a leading integrated global CDMO, supporting over 500 global customers across the pharmaceutical and biotechnology ecosystem. During the year, the Company also continued strategic investments, including a commitment of US$90 million expansion in sterile
More news about: Piramal Pharma Limited
Jul 07, 2026, 08:36 ET Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
continued to strengthen its position as a leading integrated global CDMO, supporting over 500 global customers across the pharmaceutical and biotechnology ecosystem. During the year, the Company also continued strategic investments, including a commitment of US$90 million expansion in sterile
More news about: Piramal Pharma Limited
Jul 07, 2026, 08:30 ET FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
HOUSTON, July 7, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts
More news about: FibroBiologics, Inc.
Jul 07, 2026, 08:30 ET EDX Markets Closes $76 Million Series C Funding Round Led by SBI Holdings to Enhance Institutional Digital Asset Infrastructure
within an internet-based financial ecosystem. In addition to its financial services, SBI Group has expanded into areas such as digital assets, biotechnology, and media. In 2022, it announced a capital and business alliance with Sumitomo Mitsui Financial Group (SMFG), followed by a similar partnership
More news about: EDX Markets
Jul 07, 2026, 08:20 ET TRAUMAGEL Study Highlights Sustained Hemorrhage Control and Tourniquet Removal Without Rebleeding
NEW YORK, July 7, 2026 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced the publication of a peer-reviewed study evaluating the use of TRAUMAGEL®
More news about: Cresilon
Jul 07, 2026, 08:05 ET Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
over four years with 25% of the grant vesting each year.About RigelRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders
More news about: Rigel Pharmaceuticals, Inc.